Medicare open enrollment starts Thursday, October 15, and runs until December 7 for coverage effective January 1, 2027, affecting more than 70 million enrollees. Key changes include a rise in the Part D out-of-pocket cap to $2,400 from $2,100, a standard deductible increase from $615 to $700, and the early end of a temporary Part D premium subsidy. Fifteen drugs, including Ozempic, Wegovy and Rybelsus, will get Medicare-negotiated prices from January 1, which CMS expects to lower prescription drug coverage by $685 million in 2027. Social Security benefits will rise 3.6%, about $75 more per month for nearly 72 million people. President Trump’s one-time $90 Part B premium payments reach over 20 million enrollees but exclude roughly 35 million Medicare Advantage enrollees.
Summary written by Upside AI from the original article. Read the source for full details.
Read the original on 983try.iheart.com ↗
Related news
- Medicare Open Enrollment Begins , 2027 Plan Changes Announced
Medicare open enrollment starts Thursday (October 15) and runs until December 7, with changes taking effect January 1, 2027 for more than 70 million enrollees. The Part D out-of-pocket cap rises to $2,400 from $2,100 and the standard deductible increases from $615 to $700, while a temporary Part D premium subsidy ends early at year's end. Social Security benefits will rise 3.6 percent in 2027, about $75 more per month for nearly 72 million recipients. Medicare-negotiated prices take effect for 15 drugs, including Ozempic and Wegovy, and CMS projects the change will reduce prescription drug coverage by $685 million in 2027. President Trump also announced one-time $90 payments in October for more than 20 million Medicare enrollees to help with Part B premiums, costing about $2 billion.
- Medicare Open Enrollment Begins, 2027 Plan Changes Announced
Medicare open enrollment runs from Thursday, October 15, to December 7, letting more than 70 million enrollees choose plans effective January 1, 2027. The Social Security Administration set a 3.6 percent cost-of-living increase for 2027, adding $75 a month for nearly 72 million beneficiaries. The Part D out-of-pocket cap will rise from $2,100 in 2026 to $2,400 in 2027, and the standard deductible from $615 to $700, while a temporary Part D premium subsidy started in 2024 will end early at year's end. CMS expects only modest premium increases for most people, and negotiated prices for 15 drugs, including Ozempic and Wegovy, take effect January 1, with CMS projecting a $685 million effect on drug costs in 2027. President Trump also announced one-time $90 payments in October to more than 20 million people paying Part B premiums, costing about $2 billion.
- Medicare Open Enrollment Begins , 2027 Plan Changes Announced
Medicare open enrollment runs from Thursday (October 15) to December 7, letting more than 70 million enrollees choose coverage effective January 1, 2027. The Social Security cost-of-living adjustment rises 3.6% in 2027, about $75 more per month for nearly 72 million beneficiaries. The Part D out-of-pocket cap rises from $2,100 to $2,400 and the standard deductible from $615 to $700, while a temporary Part D premium subsidy ends early at year's end. Medicare-negotiated prices for 15 drugs, including Ozempic, Wegovy and Rybelsus, take effect January 1, and CMS estimates the change will lower prescription drug coverage by $685 million in 2027. President Trump announced one-time $90 payments in October for more than 20 million enrollees to help with Part B premiums, costing about $2 billion, but not for roughly 35 million Medicare Advantage enrollees or other groups.
- Medicare Open Enrollment Begins, 2027 Plan Changes Announced
Medicare open enrollment runs from October 15 to December 7, letting more than 70 million enrollees choose traditional Medicare, Medicare Advantage plans or prescription drug plans for coverage starting January 1, 2027. Social Security benefits will rise 3.6% in 2027, about $75 more per month for nearly 72 million recipients, while the annual out-of-pocket cap for Part D drugs goes from $2,100 to $2,400 and the standard deductible from $615 to $700. The temporary Part D premium subsidy will end early at year's end, though CMS projects only modest price increases for most people. Negotiated Medicare prices for 15 drugs, including Ozempic and Wegovy, take effect January 1, and President Trump announced one-time $90 payments for more than 20 million Part B enrollees, costing about $2 billion and excluding roughly 35 million Medicare Advantage enrollees.
- Medicare Open Enrollment Begins , 2027 Plan Changes Announced
Medicare open enrollment runs from October 15 to December 7 for coverage starting January 1, 2027, affecting more than 70 million enrollees facing drug coverage and cost changes. The Part D out-of-pocket cap rises to $2,400 from $2,100, and the standard deductible increases from $615 to $700. A temporary Part D premium subsidy will end early at year's end, though CMS projects only modest increases for most people. Medicare-negotiated prices for 15 drugs, including Ozempic and Wegovy, take effect January 1. Separately, President Trump announced one-time payments of $90 in October to more than 20 million Part B enrollees, excluding roughly 35 million Medicare Advantage enrollees.
- Medicare Open Enrollment Begins, 2027 Plan Changes Announced
Medicare open enrollment runs from October 15 to December 7 for coverage effective January 1, 2027, affecting more than 70 million enrollees. Beneficiaries can choose traditional Medicare, private Medicare Advantage plans, or prescription drug plans. The Social Security Administration says benefits will rise 3.6% in 2027, about $75 more per month for nearly 72 million recipients. The Part D out-of-pocket cap rises from $2,100 in 2026 to $2,400 in 2027, the standard deductible increases from $615 to $700, and a temporary Part D premium subsidy will end early at year's end. Negotiated prices for 15 drugs take effect January 1, and CMS projects a $685 million impact on Medicare prescription drug coverage in 2027.
Related markets
Latest news
- Winning over Vingroup and Sun Group with concrete and special materials: Vietnamese company's profit up 136%, chairman speaks out
Song Da Cao Cuong (SCL) reported Q3/2026 profit of VND 38 billion, up 136%, on net revenue of over VND 263 billion (up nearly 98%), while gross profit margin rose from about 36% to 41%. For the first nine months, revenue reached nearly VND 666 billion (up 81%) and after-tax profit nearly VND 94 billion, already exceeding more than 110% of its full-year profit target. Chairman Kieu Van Mat attributed the results to technology upgrades, production line optimization and capacity expansion, with several new plants expected to start operations by November 2026. The company said it spent more than two years testing its products before Vingroup accepted them; Vingroup's share of its business has fallen to about 25% as customers expanded to around 10 major groups and exports began to Laos, Cambodia and the Philippines. Over the past two years, the company has invested about VND 1,000 billion in factories and technology.
- Coteccons Chairman Bolat Duisenov reveals new direction: expanding home construction for individual customers
At the annual general meeting on October 20, Coteccons (HoSE: CTD) set fiscal 2027 targets of VND 42,000 billion in revenue and VND 1,050 billion in after-tax profit, and said it is considering expanding into residential construction for individual customers (B2C). In fiscal 2026, net revenue reached VND 34,340 billion (up 38%, 115% of plan) and after-tax profit VND 788 billion (up 73%); new contract wins totaled VND 60,307 billion and backlog was about VND 70,000 billion. In the first quarter of the new fiscal year, the company booked revenue of VND 11,270 billion and profit of VND 306 billion, but new contract value of VND 14,519 billion was lower than a year earlier; the company said it is tightening criteria for selecting clients and projects. Coteccons is also working with Microsoft, is expected to become a strategic partner of Workday, and targets raising its ROE from 10% to 15-18% by 2030.
- UPS Yields 6.7% After Firing Amazon. Here's Whether the Dividend Survives 2027.
UPS shares yield 6.7% as of October 16. The company has moved away from high-volume, low-margin Amazon deliveries and froze its dividend earlier this year, ending a 16-year streak of increases. The article says the payout will likely remain frozen through 2026 and 2027, citing competition from 10- and 30-year Treasury yields above 5% and other industrial dividend payers, but calls the dividend's safety questionable: UPS generated $5.47 billion in free cash flow in 2025, with $5.4 billion going to dividends, and free cash flow is projected to fall to $5.05 billion in 2026 and $5.01 billion in 2027, with the dividend absorbing about 98% of 2026 free cash flow. Rising competition and high fuel prices add pressure, and the article suggests investors may find more safety in the industrial sector.
- Asian shares mostly decline after AI stocks lead a rebound on Wall Street
Asian shares mostly fell in cautious trading on Tuesday after AI-related stocks rebounded on Wall Street, while other sectors stayed shaky and oil prices stayed high. Japan's Nikkei 225 slipped 0.6% to 64,512.35 in early trading, South Korea's Kospi dropped 2.8%, and Australia's S&P/ASX 200 lost 0.8%. On Wall Street, the S&P 500 rose 0.4% and the Nasdaq gained 1.1%, helped by Nvidia's 1.4% gain, while most stocks outside AI and tech fell and the Dow slipped 0.1%. The 10-year Treasury yield climbed to 5.14%, and U.S. crude rose to $103.50 a barrel and Brent to $109.47, as uncertainty about when the energy industry will return to normal after the war with Iran means oil is unlikely to ease soon.
- Asian shares mostly decline after AI stocks lead a rebound on Wall Street
Asian shares mostly fell in cautious trading Tuesday after AI-related stocks rebounded on Wall Street, while other sectors stayed shaky and oil prices remained high. Japan's Nikkei 225 slipped 0.6% to 64,512.35, Australia's S&P/ASX 200 lost 0.8% to 8,772.10, and South Korea's Kospi dropped 2.8% to 5,605.31. On Wall Street, the S&P 500 rose 0.4% and the Nasdaq rallied 1.1%, helped by Nvidia, while the Dow fell 0.1%. The 10-year Treasury yield climbed to 5.14%, and U.S. crude rose 0.15% to $103.50 a barrel as uncertainty over the war with Iran kept oil prices elevated.
- What Could X-Energy (XE) Gain From Its 960MW Indiana Nuclear Project?
X-Energy (NasdaqGS:XE), American Electric Power and Amazon agreed to assess a 960 MW advanced nuclear project in Indiana using Xe-100 reactors, on a former coal plant site. Under the joint development agreement, Amazon would provide development funding and commit to a long-term power purchase. The article says the deal offers commercial validation for X-Energy's reactor platform rather than immediate financial relief, as the company, with a $4.3b market cap, reported $150.28 million in revenue, a $448.87 million loss, and a 20.2x price-to-sales ratio. The next key milestone is whether the study reaches a final investment decision for the Sullivan County site.
Get the briefing on Telegram or Zalo
Join the Upside Telegram channel or Zalo group for the Vietnam stocks and gold briefing at 8:00 and 19:00 (Vietnam time) on trading days, plus a weekly wrap on Saturday morning.